Chembio Diagnostics (CEMI -1.3%) says it's entered into a six-month follow-on, milestone-based...

|About: Chembio Diagnostics, Inc. (CEMI)|By:, SA News Editor

Chembio Diagnostics (CEMI -1.3%) says it's entered into a six-month follow-on, milestone-based development agreement with a private contracting organization to implement and provide technical oversight relating to pandemic preparedness on behalf of the US Centers for Disease Control and Prevention, for a rapid, POC influenza immunity test utilizing CEMI's patented Dual Path Platform technology.